Phase 3 Trial of Phosphate Replacement Fluid for AKI CRRT Sepsis Patients in China
Summary
A Phase 3 clinical trial (NCT07550894) evaluating phosphate replacement fluid for critically ill patients with acute kidney injury undergoing continuous renal replacement therapy and sepsis has been registered on ClinicalTrials.gov. The trial is conducted in China and represents an interventional study focused on electrolyte management in severe kidney injury. This is a standard clinical trial registration entry providing public transparency on ongoing research.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.
What changed
A new clinical trial registration has been added to ClinicalTrials.gov for a Phase 3 study evaluating the efficacy and safety of phosphate replacement fluid in patients with acute kidney injury requiring continuous renal replacement therapy who have sepsis. The trial is classified as interventional and is being conducted at sites in China.
Principal investigators and sponsors conducting similar critical care nephrology research should note this competitive development in the phosphate replacement therapy space. Clinical sites specializing in CRRT and sepsis management may wish to monitor enrollment progress and study outcomes for potential implications on treatment protocols.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.